Although multiple studies revealed TGF-β1’s role in morphologic manifestations and clinical characteristics of diabetic nephropathy (DN), the stimuli that activate the TGF-β/SMAD pathway in the podocyte remain unclear13,14. The gene discussed is TGFB1; the disease is diabetic kidney disease.